Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer

被引：0
|
作者：
Yu, Guangbo [1 ]
Zhang, Zigeng [2 ]
Eresen, Aydin [2 ,3 ]
Hou, Qiaoming [2 ]
Amirrad, Farideh [4 ]
Webster, Sha [4 ]
Nauli, Surya [4 ,5 ]
Yaghmai, Vahid [2 ,3 ]
Zhang, Zhuoli [1 ,2 ,3 ,6 ]
机构：
[1] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92617 USA
[2] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92868 USA
[3] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA 92612 USA
[4] Chapman Univ, Harry & Diane Rinker Hlth Sci Campus, Dept Biomed & Pharmaceut Sci, Irvine, CA 92618 USA
[5] Univ Calif Irvine, Dept Med, Irvine, CA 92868 USA
[6] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92617 USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 22期
基金：
美国国家卫生研究院;
关键词：
PDAC; immunotherapy; immune checkpoint inhibitors; radiomics; artificial intelligence; deep learning; machine learning; PD-1; BLOCKADE; ANTI-CTLA-4; IMMUNOTHERAPY; PD-1/PD-L1; GUIDELINES; CRITERIA; LIGANDS; TUMORS; TRIAL;
D O I：
10.3390/ijms252212038
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Pancreatic cancer remains one of the most lethal cancers, primarily due to its late diagnosis and limited treatment options. This review examines the challenges and potential of using immunotherapy to treat pancreatic cancer, highlighting the role of artificial intelligence (AI) as a promising tool to enhance early detection and monitor the effectiveness of these therapies. By synthesizing recent advancements and identifying gaps in the current research, this review aims to provide a comprehensive overview of how AI and immunotherapy can be integrated to develop more personalized and effective treatment strategies. The insights from this review may guide future research efforts and contribute to improving patient outcomes in pancreatic cancer management.
引用
收藏
页数：14
相关论文
共 50 条
  • [41] Concomitant medications and immune checkpoint inhibitor therapy for cancer: causation or association?
    Hussain, Nadiya
    Naeem, Muntaha
    Pinato, David J.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 55 - 61
  • [42] Cutaneous Toxicities in Lung Cancer Patients on Immune Checkpoint Inhibitor Therapy
    Keiser, Monika F.
    Patel, Anisha B.
    Altan, Mehmet
    CLINICAL LUNG CANCER, 2021, 22 (03) : 195 - +
  • [43] Immune thrombocytopenia after immune checkpoint inhibitor therapy
    Amanam, Idoroenyi
    Gupta, Rohan
    Pullarkat, Vinod
    Mei, Matthew
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (03) : 677 - 681
  • [44] Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
    Boland, Julia L.
    Zhou, Qin
    Iasonos, Alexia E.
    O'Cearbhaill, Roisin E.
    Konner, Jason
    Callahan, Margaret
    Friedman, Claire
    Aghajanian, Carol
    Sabbatini, Paul
    Zamarin, Dmitriy
    Cadoo, Karen A.
    GYNECOLOGIC ONCOLOGY, 2020, 158 (02) : 303 - 308
  • [45] The role of PET molecular imaging in immune checkpoint inhibitor therapy in lung cancer: Precision medicine and visual monitoring
    Yao, Yuan
    Zhou, Xin
    Zhang, Annan
    Ma, Xiaopan
    Zhu, Hua
    Yang, Zhi
    Li, Nan
    EUROPEAN JOURNAL OF RADIOLOGY, 2022, 149
  • [46] Predicting immune checkpoint inhibitor response with mathematical modeling
    Butner, Joseph D.
    Wang, Zhihui
    IMMUNOTHERAPY, 2021, 13 (14) : 1151 - 1156
  • [47] Predicting response to immune checkpoint therapy using an mutation burden threshold
    Panda, Anshuman
    Betigeri, Anil
    Subramanian, Kalyanasundaram
    Hirshfield, Kim
    Rodriguez, Lorna
    Ganesan, Shridar
    Bhanot, Gyan
    CANCER RESEARCH, 2016, 76
  • [48] Predicting survival benefits of immune checkpoint inhibitor therapy in lung cancer patients: a machine learning approach using real-world data
    Pan, Lingyun
    Mu, Li
    Lei, Haike
    Miao, Siwei
    Hu, Xiaogang
    Tang, Zongwei
    Chen, Wanyi
    Wang, Xiaoxiao
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024,
  • [49] Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study
    Luo, Qiankun
    Dong, Yifei
    Liu, Pan
    He, Chao
    Chen, Lei
    Zhang, Kailun
    Pan, Changjie
    Gao, Yahui
    Qin, Tao
    IMMUNOTARGETS AND THERAPY, 2024, 13 : 45 - 54
  • [50] Monitoring of thyroid function test abnormalities in cancer patients undergoing immune checkpoint inhibitor therapy in a community based cancer center
    Copur, Mehmet Sitki
    Evans, Spencer
    Olsen, Jon
    Schilling, Sonja
    Wurdeman, Julie
    Obermiller, Angela Mae
    Ramaekers, Ryan C.
    Gauchan, Dron
    Crockett, David
    Clark, Douglas
    Schriner, Megan
    Nelson, Deborah
    McDonald, Monica
    Kezeor, Jami
    Norvell, Max
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345